Wilbert Jordan
Infectious Disease · Paramount, CANPI 1053474783
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (38.2%), speaking fees and grants — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Viiv Healthcare Company at 34.9% of the total. Reporting peaked in 2019 at $29,563 and has fallen 98.2% since, to $544 in 2022. Among infectious disease clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 216 payments — averaging $242.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$18K
- Gilead$18K
- Janssen Scientific Affairs, LLC$7K
- Roche Diagnostics Corporation$4K
- Theratechnologies Inc.$3K
- Merck$574
- plus $1K from 6 others
Across 13 payments — averaging $536.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$7K
What the payments were for
- Consulting fees$20,02038%
- Speaking & faculty fees$17,98034%
- Grants$6,50012%
- Travel & lodging$2,5505%
- Food & beverage$5,40810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 63 | $18,331 |
| Gilead | 60 | $18,280 |
| Janssen Scientific Affairs, LLC | 3 | $6,500 |
| Roche Diagnostics Corporation | 6 | $3,968 |
| Theratechnologies Inc. | 9 | $3,436 |
| Merck | 23 | $574 |
| Johnson & Johnson(2 entities) | 17 | $439 |
| AbbVie | 6 | $407 |
| EMD Serono, Inc. | 26 | $384 |
| Heron Therapeutics, Inc. | 1 | $112 |
| Melinta Therapeutics, LLC | 1 | $16 |
| Napo Pharmaceuticals Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$52,458 in reported general payments places this provider in the 90th percentile of 856 infectious disease providers in California.
Other infectious disease in Paramount
- Claire PomeroySacramento$2.6M
- Javeed SiddiquiRoseville$1.5M
- George SakoulasSan Diego$902K
- Arthur JengSylmar$766K
- James McKinnellTorrance$762K
- Jay GladsteinLos Angeles$657K
- Tulika SinghOrange$654K
- Otto YangLos Angeles$472K
- Franco FelizartaBakersfield$440K
- Shawn HasslerSan Francisco$433K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.